Tonix Pharmaceuticals Holding Corp. (TNXP) Free cash flow 2016–2025
Tonix Pharmaceuticals Holding Corp. (TNXP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$103.2MFY2025 · since FY2016: -$37.4M → -$103.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$103.2M | -69.1% |
| FY2024 | -$61.0M | +44.5% |
| FY2023 | -$109.9M | +24.8% |
| FY2022 | -$146.2M | -31.9% |
| FY2021 | -$110.9M | -94.1% |
| FY2020 | -$57.1M | -114.0% |
| FY2019 | -$26.7M | -11.4% |
| FY2018 | -$24.0M | -25.3% |
| FY2017 | -$19.1M | +48.8% |
| FY2016 | -$37.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice